Market Live Email

AstraZeneca's Tezspire recommended for US approval, Elixirr reports record interim results

By Iain Gilbert

Date: Monday 22 Sep 2025

(Sharecast News) - LONDON PRE-OPEN

The FTSE 100 was expected to open 11.6 points softer ahead of the bell on Monday after wrapping up the previous session 0.12% lower at 9,216.67.


STOCKS TO WATCH

AstraZeneca and Amgen said on Monday that their Tezspire drug has been...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page